Ajanta Pharma Limited (AJANTPHARM) - Total Assets

Latest as of September 2025: Rs56.72 Billion INR ≈ $613.45 Million USD

Based on the latest financial reports, Ajanta Pharma Limited (AJANTPHARM) holds total assets worth Rs56.72 Billion INR (≈ $613.45 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Ajanta Pharma Limited - Total Assets Trend (2005–2025)

This chart illustrates how Ajanta Pharma Limited's total assets have evolved over time, based on quarterly financial data. Also see Ajanta Pharma Limited stock valuation for the company's overall valuation and market capitalisation.

Ajanta Pharma Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Ajanta Pharma Limited's total assets of Rs56.72 Billion consist of 56.7% current assets and 43.3% non-current assets. Review Ajanta Pharma Limited (AJANTPHARM) financial obligations to assess the company's total debt and financial obligations.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	3.5%
Accounts Receivable	Rs11.83 Billion	23.6%
Inventory	Rs9.04 Billion	18.0%
Property, Plant & Equipment	Rs18.92 Billion	37.7%
Intangible Assets	Rs465.20 Million	0.9%
Goodwill	Rs0.00	0.0%

Asset Composition Trend (2005–2025)

This chart illustrates how Ajanta Pharma Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See AJANTPHARM stock price for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Ajanta Pharma Limited's current assets represent 56.7% of total assets in 2025, a decrease from 61.1% in 2005.
Cash Position: Cash and equivalents constituted 3.5% of total assets in 2025, up from 1.3% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 28.0% in 2005.
Asset Diversification: The largest asset category is property, plant & equipment at 37.7% of total assets.

Ajanta Pharma Limited Competitors by Total Assets

Key competitors of Ajanta Pharma Limited based on total assets are shown below.

Company	Country	Total Assets
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Yunnan Baiyao Group Co Ltd SHE:000538	China	CN¥53.34 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	China	CN¥5.17 Billion
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Harbin Gloria Pharmaceuticals SHE:002437	China	CN¥3.14 Billion
Jiuzhitang Co Ltd SHE:000989	China	CN¥5.73 Billion
Renhe Pharmacy Co Ltd SHE:000650	China	CN¥7.93 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion

Ajanta Pharma Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.93	3.07	3.16
Quick Ratio	2.23	2.14	2.15
Cash Ratio	0.00	0.00	0.00
Working Capital	Rs22.34 Billion	Rs18.86 Billion	Rs13.61 Billion

Ajanta Pharma Limited - Advanced Valuation Insights

This section examines the relationship between Ajanta Pharma Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	8.29
Latest Market Cap to Assets Ratio	0.10
Asset Growth Rate (YoY)	8.1%
Total Assets	Rs50.15 Billion
Market Capitalization	$4.81 Billion USD

Valuation Analysis

Below Book Valuation: The market values Ajanta Pharma Limited's assets below their book value (0.10x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Ajanta Pharma Limited's assets grew by 8.1% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Ajanta Pharma Limited (2005–2025)

The table below shows the annual total assets of Ajanta Pharma Limited from 2005 to 2025.

Year	Total Assets	Change
2025-03-31	Rs50.15 Billion ≈ $542.35 Million	+8.12%
2024-03-31	Rs46.38 Billion ≈ $501.62 Million	-0.87%
2023-03-31	Rs46.79 Billion ≈ $506.02 Million	+15.37%
2022-03-31	Rs40.56 Billion ≈ $438.60 Million	+7.33%
2021-03-31	Rs37.79 Billion ≈ $408.65 Million	+13.86%
2020-03-31	Rs33.19 Billion ≈ $358.90 Million	+23.09%
2019-03-31	Rs26.96 Billion ≈ $291.58 Million	+10.11%
2018-03-31	Rs24.49 Billion ≈ $264.81 Million	+34.34%
2017-03-31	Rs18.23 Billion ≈ $197.12 Million	+23.04%
2016-03-31	Rs14.81 Billion ≈ $160.21 Million	+29.23%
2015-03-31	Rs11.46 Billion ≈ $123.97 Million	+20.75%
2014-03-31	Rs9.49 Billion ≈ $102.67 Million	+32.18%
2013-03-31	Rs7.18 Billion ≈ $77.67 Million	+10.70%
2012-03-31	Rs6.49 Billion ≈ $70.17 Million	+24.25%
2011-03-31	Rs5.22 Billion ≈ $56.47 Million	+5.47%
2010-03-31	Rs4.95 Billion ≈ $53.54 Million	+6.96%
2009-03-31	Rs4.63 Billion ≈ $50.06 Million	+28.61%
2008-03-31	Rs3.60 Billion ≈ $38.92 Million	+34.15%
2007-03-31	Rs2.68 Billion ≈ $29.01 Million	+11.41%
2006-03-31	Rs2.41 Billion ≈ $26.04 Million	+11.02%
2005-03-31	Rs2.17 Billion ≈ $23.46 Million	--

About Ajanta Pharma Limited

NSE:AJANTPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$4.81 Billion

Rs445.22 Billion INR

Market Cap Rank

#3663 Global

#161 in India

Share Price

Rs3563.60

Change (1 day)

+1.80%

52-Week Range

Rs2388.40 - Rs3718.20

All Time High

Rs3718.20